Lessons to learn from the patent cliff

Patents are running out on blockbuster drugs in an industry that makes up a third of Ireland's GDP, writes Tina-Marie O'Neill.

6th January, 2013
Pharmaceutical manufacturing: when patents for many drugs expire, generic manufacturers can produce and sell the drug at lower cost. Photo: Bloomberg

Over the past week, the world has been convulsed by the issue of the US fiscal cliff. But in Ireland, it is the so-called patent cliff that continues to concern policy-makers for the country's biggest export industry, pharmaceuticals.

The patents for many drugs produced in Ireland expire after 20 years. When this happens, generic manufacturers can produce and sell the drug at lower cost. The result is a sharp fall in revenue to the drug's...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago